Omega Fund V, L.P.'s Net Worth
Estimate Recalculated Jun 20, 2025 09:17PM EST
Who is Omega Fund V, L.P.
Omega Fund V, L.P. has an estimated net worth of $242 Million. This is based on reported shares across multiple companies, which include Nuvation Bio Inc., Morphic Holding, Inc., IMMUNIC, INC., Gossamer Bio, Inc., Kronos Bio, Inc., Translate Bio, Inc., and Trevi Therapeutics, Inc..
SEC CIK
Omega Fund V, L.P.'s CIK is 0001641354
Past Insider Trading and Trends
2019 was Omega Fund V, L.P.'s most active year for acquiring shares with 5 total transactions. Omega Fund V, L.P.'s most active month to acquire stocks was the month of September. 2021 was Omega Fund V, L.P.'s most active year for disposing of shares, totalling 208 transactions. Omega Fund V, L.P.'s most active month to dispose stocks was the month of March. 2020 saw Omega Fund V, L.P. paying a total of $14,465,728.85 for 3,798,832 shares, this is the most they've acquired in one year. In 2021 Omega Fund V, L.P. cashed out on 14,237,949 shares for a total of $92,064,268.53, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
